🇺🇸 FDA
Patent

US 7745144

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

granted A61KA61K38/00A61P

Quick answer

US patent 7745144 (Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P29/00